Advertisement
Advertisement

ARTL

ARTL logo

Artelo Biosciences, Inc. Common Stock

5.31
USD
Sponsored
-0.10
-1.85%
Apr 15, 16:00 UTC -4
Closed
exchange

After-Market

5.32

+0.01
+0.24%

Artelo Biosciences, Inc. Common Stock Profile

About

Artelo Biosciences Inc. is a biopharmaceutical company. It is engaged in development and commercialization of proprietary therapeutics targeting the endocannabinoid system. The company's product pipeline consists of ART27.13, ART12.11 and ART26.12 which are in clinical stage. Artelo Biosciences Inc. is based in La Jolla, CA.

Info & Links

CEO

Gregory D. Gorgas

Headquarters

505 LOMAS SANTA FE, SUITE 160
SOLANA BEACH, CA 92075, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.artelobio.com

Auditor

MaloneBailey, LLP

Share holders

167

Employees

7

Artelo Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

4.35M

Enterprise Value

4.36M

Enterprise Value/EBITDA(ttm)

-0.39

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-3401.09%

Return on Invested Capital(ttm)

685.69%

Return on Assets(ttm)

-345.03%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-11.25M

Net Income Available to Common(ttm)

-12.88M

Diluted EPS(ttm)

-62.76

Share Statistics

Beta (5Y Monthly)

0.41

52-Week Change

-69.57%

S&P 500 52-Week Change

30.14%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

708.19K

Dividend Yield

0.00%

Float4

789.00K

% Held by Insiders

11.50%

% Held by Institutions

0.87%

Balance Sheet

Total Cash(mrq)

600.00K

Total Cash Per Share(mrq)

0.85

Total Debt(mrq)

609.00K

Total Debt/Equity(mrq)

-47.88%

Current Ratio(mrq)

0.17%

Quick Ratio(mrq)

0.17%

Book Value Per Share(mrq)

-1.89

Cash Flow

Operating Cash Flow Per Share(ytd)

-24.84

Free Cash Flow(ytd)

-8.52M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement